Financial Contrast: Ambu A/S (OTCMKTS:AMBBY) and Envoy Medical (NASDAQ:COCH)

Envoy Medical (NASDAQ:COCH) and Ambu A/S (OTCMKTS:AMBBY) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, dividends and earnings.

Profitability

This table compares Envoy Medical and Ambu A/S’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-11,304.83%	N/A	-144.13%
Ambu A/S	8.18%	8.49%	6.75%

Analyst Recommendations

This is a breakdown of recent recommendations for Envoy Medical and Ambu A/S, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	1	1	2	0	2.25
Ambu A/S	0	1	0	0	2.00

Envoy Medical currently has a consensus price target of $21.67, suggesting a potential upside of 233.33%. Given Envoy Medical’s stronger consensus rating and higher possible upside, equities research analysts clearly believe Envoy Medical is more favorable than Ambu A/S.

Institutional & Insider Ownership

8.6% of Envoy Medical shares are owned by institutional investors. 7.2% of Envoy Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Volatility and Risk

Envoy Medical has a beta of 1.97, indicating that its share price is 97% more volatile than the S&P 500. Comparatively, Ambu A/S has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500.

Earnings & Valuation

This table compares Envoy Medical and Ambu A/S”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envoy Medical	$240,000.00	2,090.56	-$23.76 million	($0.76)	-8.55
Ambu A/S	$894.37 million	3.06	$90.19 million	$0.30	38.80

Ambu A/S has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Ambu A/S, indicating that it is currently the more affordable of the two stocks.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

About Ambu A/S

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. The company was founded in 1937 and is headquartered in Ballerup, Denmark.